Botulinum in selected neurological disorders - review

Introduction and objective. Botulinum toxin (BoNT) has been used in medicine for many years. BoNT, prevents acetylcholine from being released into synapses, causing flaccid muscles paralysis. The article reviews the current knowledge of botulinum toxin application in the treatment of neurological diseases, focusing on therapeutic efficacy and side-effects. The aim of the review is to analyze the largest possible number of neurological conditions in which the application of botulinum toxin

• Publication year

  2021

• Venue

  Journal of Pre-Clinical and Clinical Research

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.26444/jpccr/142880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutically relevant features of botulinum toxin drugs.

  2020cited by this paper
• Botulinum toxin type A for controlling bruxism assessed with computerized occlusal analysis: A pilot study

  2020cited by this paper
• Botulinum Toxin Therapy for Managing Sleep Bruxism: A Randomized and Placebo—Controlled Trial

  2020cited by this paper
• Consensus of the Iberoamerican Oculoplastic Society for diagnosis and management of facial dystonia.

  2019cited by this paper
• Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study

  2019cited by this paper
• International Guidelines for the Treatment of Huntington's Disease

  2019cited by this paper
• A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.

  2019cited by this paper
• Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities

  2019cited by this paper
• SIAXI

  2019cited by this paper
• Progressive Cervical Spondylotic Myelopathy Caused by Tic Disorders in a Young Adult with Tourette Syndrome

  2019cited by this paper
• The History of Blepharospasm in Medicine

  2018cited by this paper
• Rekomendacje interdyscyplinarnej grupy ekspertów w zakresie kompleksowego i długofalowego leczenia spastyczności toksyną botulinową typu A

  2018cited by this paper
• The effects of different injection techniques of botulinum toxin a in post-stroke patients with plantar flexor spasticity

  2018cited by this paper
• Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.

  2018cited by this paper
• Botulinum toxin in movement disorders

  2018cited by this paper
• Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm

  2018cited by this paper
• Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance

  2018cited by this paper
• The colorful spectrum of Tourette syndrome and its medical, surgical and behavioral therapies.

  2018cited by this paper
• Onabotulinum toxin-A injections for sleep bruxism

  2018cited by this paper
• Incobotulinum toxin A in Parkinson's disease with foot dystonia: A double blind randomized trial.

  2018cited by this paper
• Developments in the treatment of benign essential blepharospasm

  2018cited by this paper
• Botulinum Toxin Type A for Pain in Advanced Parkinson’s Disease

  2017cited by this paper
• Management of oral secretions in neurological disease

  2017cited by this paper
• Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?

  2017cited by this paper
• Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology

  2017cited by this paper
• Botulinum toxin therapy: functional silencing of salivary disorders

  2017cited by this paper
• Praktyczne aspekty leczenia migreny przewlekłej toksyną botulinową typu A

  2017cited by this paper
• The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A.

  2017cited by this paper
• Botulinum Toxin in Parkinson Disease Tremor: A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach.

  2017cited by this paper
• Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism

  2017cited by this paper
• AbobotulinumtoxinA (Dysport®) Improves Function According to Goal Attainment in Children With Dynamic Equinus Due to Cerebral Palsy

  2017cited by this paper
• Botulinum toxin A in the treatment of trigeminal neuralgia

  2016cited by this paper
• Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache

  2016cited by this paper
• The effect of laser and botulinum toxin in the treatment of myofascial pain and mouth opening: A randomized clinical trial.

  2016cited by this paper
• Botulinum Toxin Treatment in Neurology

  2016cited by this paper
• Botulinum toxin for motor and phonic tics in Tourette's syndrome.

  2016cited by this paper
• Leczenie toksyną botulinową spastyczności kończyny dolnej po udarze mózgu

  2016cited by this paper
• Botulinum toxin type A for neuropathic pain in patients with spinal cord injury

  2016cited by this paper
• Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.

  2016cited by this paper
• High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis

  2015cited by this paper
• Botulinum Toxin type A injections for patients with painful hallux valgus: a double-blind, randomized controlled study.

  2015cited by this paper
• Efficacy analysis of ultrasound-guided local injection of botulinum toxin type A treatment with orthopedic joint brace in patients with cervical dystonia.

  2015cited by this paper
• A Double-Blind Randomized Controlled Trial Investigating the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhea Treatment in Asian Adults with Neurological Diseases

  2015cited by this paper
• Toksyna botulinowa w leczeniu spastyczności kończyny górnej

  2015cited by this paper
• Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.

  2014cited by this paper
• Technique of injection of onabotulinumtoxin A for chronic migraine: the PREEMPT injection paradigm

  2014cited by this paper
• A Meta-analysis of Clinical Effects of Low-level Laser Therapy on Temporomandibular Joint Pain

  2014cited by this paper
• Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?

  2013cited by this paper
• A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor

  2012cited by this paper
• Botulinum toxin improves dysphagia associated with multiple sclerosis

  2011cited by this paper
• OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

  2010cited by this paper
• Membrane Fusion: Grappling with SNARE and SM Proteins

  2009cited by this paper
• Botulinum toxin B increases mouth opening in patients with spastic trismus

  2009cited by this paper
• 企画講演2 ジストニアの診断と治療―病態生理的アプローチ

  2008cited by this paper
• Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis.

  2008cited by this paper
• SNAREs — engines for membrane fusion

  2006cited by this paper
• Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.

  2006cited by this paper
• Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke

  2004cited by this paper
• Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use

  2004cited by this paper
• European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.

  2004cited by this paper
• Benign Essential Blepharospasm Among Residents of Olmsted County, Minnesota, 1976 to 1995: An Epidemiologic Study

  2003cited by this paper
• History of the clinical use of botulinum toxin A and B.

  2003cited by this paper
• Prevalence of spasticity post stroke

  2002cited by this paper
• Toxina botulínica: aplicaciones terapéuticas

  2001cited by this paper
• A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor

  2001cited by this paper
• Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial

  2001cited by this paper
• Botulinum toxin for simple motor tics

  2001cited by this paper
• Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders

  2001cited by this paper
• Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb.

  2000cited by this paper
• Evaluating the role of botulinum toxin in the management of focal hypertonia in adults

  2000cited by this paper
• Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia

  1997cited by this paper
• Clinical trials of botulinum toxin in the treatment of spasticity

  1997cited by this paper
• Differences in the prevalence of essential tremor among elderly African Americans, whites, and Hispanics in northern Manhattan, NY.

  1995cited by this paper
• Essential tremor.

  1989cited by this paper
• Identification and characterization of a novel botulinum neurotoxin

  year unknowncited by this paper

• No citing papers are available for this paper.